# Junta clínica — PT-pseudo_fc6cf5262222 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_fc6cf5262222",
  "pid": "PT-pseudo_fc6cf5262222",
  "task": 1,
  "psa": 7.5,
  "age": 61,
  "months": 1,
  "pirads": "4",
  "psad": 0.179,
  "psav": 1.49,
  "psap": 4.6,
  "vol": 42.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.0,
  "medhx": "Hypertension",
  "meds": "valsartan, metoprolol",
  "notes": "PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.",
  "pmhx": [
    "Hypertension"
  ],
  "allergies": [],
  "vitals": {
    "weight": "79 kg",
    "height": "177 cm",
    "bmi": "25.2",
    "bp": "124/76 mmHg",
    "hr": "83 bpm",
    "smoking": "Ex-smoker (34 pack-yr, quit 2006)",
    "last_dental": "3 yr ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Feb 2025",
  "enc_ref": "Dr. R. Visser (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive."
    },
    {
      "s": "History",
      "t": "A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.\nGeneral assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement."
    }
  ],
  "occupation": "self-employed contractor (carpentry)",
  "marital": "Married",
  "living": "Lives alone; adult son nearby",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "6 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Erasmus MC",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_fc6cf5262222
Task: 1

Encounter: Urology - outpatient on 22 Feb 2025.
Referrer: Dr. R. Visser (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 61-year-old male
  - PSA: 7.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.179 ng/mL²
  - PSA velocity: 1.49 ng/mL/yr
  - Prior PSA: 4.6 ng/mL
  - Prostate volume: 42.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.0 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension
  - Problem list / PMHx: Hypertension
  - Current medication: valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.

Vitals: weight 79 kg, height 177 cm, BMI 25.2, BP 124/76 mmHg, HR 83 bpm. Smoking: Ex-smoker (34 pack-yr, quit 2006).

Chief complaint: Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive.

History: A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago.

Physical examination: DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.
General assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement.

Patient info: self-employed contractor (carpentry); Married; Lives alone; adult son nearby.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Walking 45 min/day; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Vascular surgery — varicose veins consult.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.20-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 61 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 7.5 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 42 mL (1% of my signal; from log_vol, vol) · PSA density = 0.179 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.00 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 61 · DRE = Normal · PSA = 7.5 ng/mL · prostate volume = 42 mL · PSA density = 0.179 · PI-RADS = 4 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 49 men I have seen in this same situation (Positive prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 1.57: PI-RADS 4, PSA 8.4, PSAD 0.1, age 63, DRE Normal -> BIOPSY (uncertain). He wrote: "Patient on Active surveillance. Initial ISUP and MRI is needed."
  2. distance 1.94: PI-RADS 4, PSA 5.2, PSAD 0.151, age 68, DRE Normal -> BIOPSY (uncertain). He wrote: "Again missing earlier ISUP grading and if the PIRADS 4 lesion is stabile or growing"
  3. distance 2.19: PI-RADS 4, PSA 5.3, PSAD 0.1, age 56, DRE Nodus -> BIOPSY (clear). He wrote: "PIRADS 4 in a young man with a rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · PSA = 7.5 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · age = 61 · DRE = Normal · prostate volume = 42 mL · PSA density = 0.179
  not used   csPCa probability, comorbidity
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   prior biopsy = Positive
  important  age = 61 · PSA = 7.5 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 42 mL · PSA density = 0.179 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guidelines discuss using PI-RADS thresholds to guide biopsy decisions, noting that a threshold of PI-RADS $\ge 3$ is used to trigger biopsy, and that risk-adapted matrices based on PSA density and PI-RADS can guide the decision. The guideline suggests that increasing the threshold to PI-RADS $\ge 4$ could avoid a significant number of biopsies while missing some cancer.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of NO BIOPSY (p(biopsy) = 0.42) is not directly addressed by the guideline, which focuses on risk stratification using PI-RADS and PSA density. The guideline suggests that the PI-RADS score is a key variable, and the guideline makes the PI-RADS score decisive for determining the need for biopsy. The guideline requires the PI-RADS score, which is 4 for this patient, to be used in risk stratification. The guideline needs the prior grade of the biopsy to be established to determine the appropriate next step.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: the rate of change in PSA is a factor in risk stratification, which the guideline uses to assess risk.
laboratory_results - the PSA density: this value is used in risk-adapted matrices alongside PI-RADS to guide the decision.
family-history anamnesis - the family history of prostate cancer is a variable that can be used in risk stratification.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on establishing the prior biopsy grade documented in the previous notes, as the guideline suggests this is key to determining the next step.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size or status compared to an earlier study inform the decision?
  psa_trend (get_psa_trend) -> What is the PSA velocity to assess risk stratification?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy and is there a surveillance protocol?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?

On the plan itself: The moderator asked for laboratory_results, which the reading urologist does not open in this situation; dropped — every reveal beyond his is scored against us. Dropped 1 question(s) that asked for a value already printed on the panel: "Is the PI-RADS 4 lesion stable or growing?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: "Radiology Division | Erasmus MC University Medical Center | 15 February 2025. COMPARISON: new. LESION: PI-RADS 4 lesion in the right peripheral zone mid-gland, spanning 14 x 11 x 10 mm."
psa_trend: "PSA 2.9 (Nov 2022) rising to 7.5 (Feb 2025), steepest in the last year."
previous_notes: "PRIOR GRADE: not recorded. BIOPSY SESSIONS: not recorded. SURVEILLANCE: Monitoring continued without additional procedural steps during this visit. TREATMENT: none recorded."

WHAT I DID NOT OPEN
laboratory_results, as the panel indicated this was not required for the decision based on the plan.

WHAT THIS SUPPORTS
FOR sampling this patient now:
- PI-RADS 4 lesion in the right peripheral zone mid-gland (from radiology_report).
- PSA velocity of 1.49 ng/mL/yr (from psa_trend).
AGAINST sampling this patient now:
- Prior biopsy grade is not recorded (from previous_notes).

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.50 ng/mL over 4 points spanning 27 months; velocity +2.04 ng/mL per year; doubling time about 20 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 3.0-36.1.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7.5 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.11 epistemic (95% band 0.36-0.77), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 7.5 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 42 mL (4% of my signal; from log_vol, vol) · PSA density = 0.179 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_nolab; weight 1.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.51 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> decisive
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          61                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          7.5 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          42 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.179                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.00                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: uncertain.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) directly address the moderator's question Q1 by stating that the "PRIOR GRADE: not recorded" in the previous_notes.

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concludes BIOPSY based on a weighted vote, despite noting that the "documented prior grade in the opened documents: none recorded." The retrieved evidence confirms the panel's premise that the prior grade is missing.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? This question is answered by the registrar's report, which states the prior grade is "not recorded."

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: not_used / noted with the value 'not recorded' because the registrar explicitly stated this in the previous_notes, which is the key missing piece the guideline emphasizes. I would move this to 'decisive' if the guideline strongly implied that an unrecorded prior grade mandates a specific action, but here it is noted as missing. My confidence in the record as it stands is borderline because the panel's decision rests entirely on this unrecorded fact.

MY SUGGESTION TO THE CHAIR
Given that the guideline emphasizes the prior biopsy grade, and the record explicitly states it is not recorded, the panel's decision to BIOPSY is based on expert consensus rather than direct guideline application. I suggest proceeding with BIOPSY, as the clinical picture (PI-RADS 4, rising PSA velocity) supports this, but with the caveat that the decision is not fully supported by the retrieved evidence regarding the prior biopsy grade.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: uncertain)

61y male, PSA 7.5, PI-RADS 4, prior biopsy grade not recorded. Rising PSA and new PI-RADS 4 lesion suggest sampling is warranted to determine management. The lack of prior biopsy grade makes the decision uncertain, but sampling is indicated to define the extent of disease.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
